Trial Profile
A randomized, double blind, parallel, safety and efficacy study of to investigate the effect of Sugammadex on bleeding profile of living donor liver transplantation .
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 Feb 2019
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary) ; Atropine; Neostigmine
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 05 Feb 2017 Status changed from not yet recruiting to recruiting.
- 24 Oct 2016 New trial record